FDA approves Jakafi for treatment of rare blood disorder
Manufactured by Incyte Corporation, Jakafi is a new FDA-approved drug for the treatment of polycythemia vera (PV) and high-risk myelofibrosis (MF) – rare but serious blood condition that is characterized by abu...